Clinical trials
Renal Disease clinical trials
Below are recruiting renal disease clinical trials, each written for real people, not researchers. We’re tracking 261 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06439862Recruiting
Quality of life in children with posterior urethral valves
This study looks at how children with posterior urethral valves (a condition that affects urination) feel about their quality of life as they grow up. It will help doctors understand how these children are doing emotionally and socially, so they can improve care.
Bron, BronAges 6–17 - NCT04671771Recruiting
Testing a new graft for hemodialysis access in kidney failure
This study tests whether an “AV graft” implant works safely and well for people with end-stage kidney disease who need hemodialysis. It may help your dialysis access last and work better, compared with current expectations for AV grafts.
Phoenix, ArizonaAges 18–90 - NCT06536439Recruiting
Digital tool to plan kidney clamping during robotic surgery
This trial tests a new digital tool that helps surgeons plan the best way to clamp the blood supply to your kidney during robotic surgery. The tool aims to reduce damage to healthy kidney tissue while still blocking the tumor's blood flow.
AalstAges 18 years+ - NCT07053462RecruitingPhase 1/Phase 2
Gene-edited kidney transplant to lower rejection risk
This trial tests a specially edited donor kidney designed to reduce the chance of rejection, especially for people with high sensitivity to donor kidneys. If it works, it could make more kidneys available for those who have a hard time finding a match.
Beijing, ChangpingAges 16–85 - NCT06842927Enrolling by invitation
A tool to measure how well peritoneal dialysis works
This study is testing a new computer tool that helps doctors see how well peritoneal dialysis (a type of kidney treatment done at home) removes waste from your body. It may help make your dialysis more effective.
TuenmenAges 18 years+ - NCT05443321Enrolling by invitation
Health information sharing during hospital transfers
This trial studies whether sharing patients’ health information between hospitals during transfers can improve outcomes. You may be included if you are moved from a specific partner hospital to Brigham and Women’s Hospital and admitted to certain hospital units.
Boston, MassachusettsAges 18 years+ - NCT07570771Recruiting
Dialysis duration effects on bladder function in transplant candidates
This study examines how long you've been on dialysis and how much urine you still produce might affect your bladder's ability to hold and stretch after a kidney transplant. Understanding this helps doctors predict how well your bladder will work after you receive a new kidney.
Karachi, SindhAges 18–65 - NCT05153967Recruiting
Study late effects after sickle cell curative treatments
This study looks at long-term health effects after curative treatments for sickle cell disease, such as bone marrow transplant. Your participation helps researchers understand what changes over time after treatment, and what might need monitoring or care.
Washington D.C., District of ColumbiaAges 4–65 - NCT03869554Recruiting
Screening for Fabry disease in people with kidney biopsy results
This study tests a screening approach to find Fabry disease in adults whose kidney biopsy findings are unclear or suggest certain kidney patterns. If Fabry disease is missed, it can delay targeted treatment, so screening may help identify people who could benefit from earlier care.
AngersAges 18 years+ - NCT04334707Recruiting
Study kidney damage in people with long-term diabetes
This study is looking at different kidney health patterns in people with diabetes, especially diabetic kidney disease and people who have not developed kidney damage despite long-term diabetes. It may help researchers understand why kidney problems happen—and what protective factors might prevent them.
Tucson, ArizonaAges 18 years+ - NCT07045155RecruitingPhase 4
Study of pegmolesatide for anemia in dialysis patients
This trial tests a new medication, pegmolesatide, to treat anemia in people who have been on dialysis for at least three months. It aims to help improve red blood cell levels without needing as many other anemia treatments.
Beijing, Beijing MunicipalityAges 18–80 - NCT05889806Enrolling by invitation
Study uses blood and tissue samples for gene and protein testing
This study collects and analyzes your donated samples (like blood or other biospecimens) to look for patterns in genes and proteins. The results may help researchers understand disease biology and improve future tests or treatments.
New Orleans, LouisianaAges 18 years+ - NCT01581424Recruiting
Study how kidney findings change in Fabry disease
This study looks at the natural course of Fabry disease in the kidneys and how different kidney test results relate to each other. It may help doctors better understand kidney progression and treatment outcomes, including for people who have or have not had enzyme replacement therapy.
Minneapolis, MinnesotaAges 1–75 - NCT07653711Recruiting
Coated aldehyde oxystarch for reducing toxins in kidney failure
This trial tests a new oral medication, coated aldehyde oxystarch, for people on dialysis. It aims to lower certain waste products in the blood that are hard to remove with standard dialysis, which may help reduce long-term complications.
BeijingAges 18 years+ - NCT05671991RecruitingPhase 4
Empagliflozin study for kidney and belly membrane function
This trial tests whether empagliflozin improves kidney health and the function of the belly’s dialysis membrane in people with end-stage kidney disease who do peritoneal dialysis. It may help by changing how well the peritoneal dialysis system works and how the kidneys perform over time.
New Haven, ConnecticutAges 18 years+ - NCT05878171Recruiting
Choices about life-saving treatment for kidney failure patients
This trial looks at what patients with kidney failure prefer for life-sustaining treatments (like whether they would want certain life-prolonging care). Your answers may help improve how future care plans are discussed and tailored to patients’ wishes.
TaipeiAges 20 years+ - NCT07426380RecruitingPhase 1
Study of eloralintide in people with and without kidney problems
This trial tests how the body handles eloralintide in people with different levels of kidney function, including those on dialysis. It may help determine if the drug is safe and effective for patients with kidney issues.
Miami Lakes, FloridaAges 18–85 - NCT06676527Recruiting
Vorolanib for advanced kidney cancer after first treatment
This trial tests a targeted therapy pill, vorolanib, for people with advanced kidney cancer that has clear cell features and has gotten worse after initial treatment. It may offer a new option when standard second-line treatments are not working.
Nanjing, JiangsuAges 18–80 - NCT05382663Recruiting
SmartPatch study for adults on dialysis with an arm access
This study looks at how well a wearable patch (“SmartPatch”) can be used safely and correctly in adults who are receiving long-term dialysis through an arm fistula or graft. It may help researchers improve how medical devices are used in people with end-stage kidney disease.
AmmanAges 18 years+ - NCT06203977RecruitingPhase 1
Can colchicine protect heart health in kidney disease?
This study tests if a low-dose anti-inflammatory medication (colchicine) can help protect the heart and blood vessels in people with advanced kidney disease or on dialysis. It aims to lower inflammation that may increase heart risks.
Edmonton, AlbertaAges 18 years+ - NCT04399941Recruiting
Ultrasound inside the blood vessel for dialysis access issues
This trial tests a special type of ultrasound placed inside a blood vessel to better understand problems with dialysis access. It may help doctors find the cause of access malfunction during your diagnostic fistulogram.
Boston, MassachusettsAges 18–85 - NCT07174622Recruiting
Long-term results for renal denervation study
This study tracks patients who have uncontrolled high blood pressure and are on a steady medication plan. It checks how kidney nerve treatment (renal denervation) works in real life over time.
Boston, MassachusettsAges 18 years+ - NCT07119424Recruiting
SGLT2 inhibitor study for older adults
This study looks at how a class of diabetes and kidney drugs called SGLT2 inhibitors affect older adults. It aims to understand the benefits for your kidneys and metabolism.
Milan, MilanAges 65 years+ - NCT06717581Recruiting
Drug interaction study for older people with HIV
This study looks at how other medicines you take for conditions like high blood pressure, diabetes, or cholesterol might interact with your HIV medication (Biktarvy) if you are 60 or older. The goal is to learn how to better manage your overall health.
BolognaAges 18 years+
Hear when a new Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for renal disease?
- Yes. Clin2 currently lists 261 recruiting renal disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a renal disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a renal disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.